vs

Side-by-side financial comparison of Genius Sports Ltd (GENI) and KRONOS WORLDWIDE INC (KRO). Click either name above to swap in a different company.

Genius Sports Ltd is the larger business by last-quarter revenue ($510.9M vs $418.3M, roughly 1.2× KRONOS WORLDWIDE INC). Genius Sports Ltd runs the higher net margin — -12.3% vs -19.8%, a 7.5% gap on every dollar of revenue. KRONOS WORLDWIDE INC produced more free cash flow last quarter ($81.9M vs $69.6M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs -6.5%).

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

Kronos Incorporated was an American multinational workforce management and human capital management cloud provider headquartered in Lowell, Massachusetts, United States, which employed more than 6,000 people worldwide.

GENI vs KRO — Head-to-Head

Bigger by revenue
GENI
GENI
1.2× larger
GENI
$510.9M
$418.3M
KRO
Higher net margin
GENI
GENI
7.5% more per $
GENI
-12.3%
-19.8%
KRO
More free cash flow
KRO
KRO
$12.3M more FCF
KRO
$81.9M
$69.6M
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
-6.5%
KRO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GENI
GENI
KRO
KRO
Revenue
$510.9M
$418.3M
Net Profit
$-63.0M
$-82.8M
Gross Margin
25.2%
-0.9%
Operating Margin
-11.5%
-15.1%
Net Margin
-12.3%
-19.8%
Revenue YoY
-1.1%
Net Profit YoY
-527.3%
EPS (diluted)
$-0.72

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENI
GENI
KRO
KRO
Q4 25
$510.9M
$418.3M
Q3 25
$335.4M
$456.9M
Q2 25
$215.2M
$494.4M
Q1 25
$119.7M
$489.8M
Q4 24
$413.0M
$423.1M
Q3 24
$285.8M
$484.7M
Q2 24
$184.1M
$500.5M
Q1 24
$97.2M
$478.8M
Net Profit
GENI
GENI
KRO
KRO
Q4 25
$-63.0M
$-82.8M
Q3 25
$-37.0M
Q2 25
$-47.3M
$-9.2M
Q1 25
$-25.5M
$18.1M
Q4 24
$-85.5M
$-13.2M
Q3 24
$-47.1M
$71.8M
Q2 24
$-35.5M
$19.5M
Q1 24
$-25.2M
$8.1M
Gross Margin
GENI
GENI
KRO
KRO
Q4 25
25.2%
-0.9%
Q3 25
24.2%
10.3%
Q2 25
19.1%
12.7%
Q1 25
10.7%
21.8%
Q4 24
16.7%
20.4%
Q3 24
20.5%
20.9%
Q2 24
18.6%
20.0%
Q1 24
9.8%
14.9%
Operating Margin
GENI
GENI
KRO
KRO
Q4 25
-11.5%
-15.1%
Q3 25
-15.3%
-4.2%
Q2 25
-21.0%
1.5%
Q1 25
-20.3%
7.8%
Q4 24
-18.0%
6.8%
Q3 24
-13.9%
8.0%
Q2 24
-16.8%
7.2%
Q1 24
-23.7%
4.1%
Net Margin
GENI
GENI
KRO
KRO
Q4 25
-12.3%
-19.8%
Q3 25
-8.1%
Q2 25
-22.0%
-1.9%
Q1 25
-21.3%
3.7%
Q4 24
-20.7%
-3.1%
Q3 24
-16.5%
14.8%
Q2 24
-19.3%
3.9%
Q1 24
-25.9%
1.7%
EPS (diluted)
GENI
GENI
KRO
KRO
Q4 25
$-0.72
Q3 25
$-0.32
Q2 25
$-0.08
Q1 25
$0.16
Q4 24
$-0.11
Q3 24
$0.62
Q2 24
$0.17
Q1 24
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENI
GENI
KRO
KRO
Cash + ST InvestmentsLiquidity on hand
$280.6M
$33.2M
Total DebtLower is stronger
$557.4M
Stockholders' EquityBook value
$724.5M
$751.1M
Total Assets
$1.1B
$1.8B
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENI
GENI
KRO
KRO
Q4 25
$280.6M
$33.2M
Q3 25
$110.2M
$27.7M
Q2 25
$110.2M
$18.9M
Q1 25
$110.2M
$20.5M
Q4 24
$100.3M
$106.7M
Q3 24
$100.3M
$94.8M
Q2 24
$100.3M
$133.8M
Q1 24
$100.3M
$120.7M
Total Debt
GENI
GENI
KRO
KRO
Q4 25
$557.4M
Q3 25
$626.2M
Q2 25
$589.3M
Q1 25
$557.2M
Q4 24
$507.4M
Q3 24
$554.3M
Q2 24
$423.7M
Q1 24
$426.9M
Stockholders' Equity
GENI
GENI
KRO
KRO
Q4 25
$724.5M
$751.1M
Q3 25
$572.4M
$804.7M
Q2 25
$572.4M
$846.8M
Q1 25
$572.4M
$847.0M
Q4 24
$573.0M
$817.0M
Q3 24
$573.0M
$847.4M
Q2 24
$573.0M
$774.6M
Q1 24
$573.0M
$774.4M
Total Assets
GENI
GENI
KRO
KRO
Q4 25
$1.1B
$1.8B
Q3 25
$792.3M
$1.9B
Q2 25
$792.3M
$1.9B
Q1 25
$792.3M
$1.9B
Q4 24
$775.7M
$1.9B
Q3 24
$775.7M
$1.9B
Q2 24
$775.7M
$1.7B
Q1 24
$775.7M
$1.7B
Debt / Equity
GENI
GENI
KRO
KRO
Q4 25
0.74×
Q3 25
0.78×
Q2 25
0.70×
Q1 25
0.66×
Q4 24
0.62×
Q3 24
0.65×
Q2 24
0.55×
Q1 24
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENI
GENI
KRO
KRO
Operating Cash FlowLast quarter
$81.9M
$92.1M
Free Cash FlowOCF − Capex
$69.6M
$81.9M
FCF MarginFCF / Revenue
13.6%
19.6%
Capex IntensityCapex / Revenue
2.4%
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$33.5M
$-40.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENI
GENI
KRO
KRO
Q4 25
$81.9M
$92.1M
Q3 25
$-4.8M
$-7.9M
Q2 25
$-1.2M
$20.7M
Q1 25
$-14.6M
$-102.4M
Q4 24
$14.9M
$49.3M
Q3 24
$-9.2M
$28.3M
Q2 24
$38.2M
Q1 24
$-43.3M
Free Cash Flow
GENI
GENI
KRO
KRO
Q4 25
$69.6M
$81.9M
Q3 25
$-14.2M
$-17.4M
Q2 25
$-5.8M
$9.5M
Q1 25
$-16.0M
$-114.4M
Q4 24
$11.3M
$37.0M
Q3 24
$-11.6M
$19.2M
Q2 24
$34.8M
Q1 24
$-48.0M
FCF Margin
GENI
GENI
KRO
KRO
Q4 25
13.6%
19.6%
Q3 25
-4.2%
-3.8%
Q2 25
-2.7%
1.9%
Q1 25
-13.4%
-23.4%
Q4 24
2.7%
8.7%
Q3 24
-4.1%
4.0%
Q2 24
7.0%
Q1 24
-10.0%
Capex Intensity
GENI
GENI
KRO
KRO
Q4 25
2.4%
2.4%
Q3 25
2.8%
2.1%
Q2 25
2.1%
2.3%
Q1 25
1.2%
2.4%
Q4 24
0.9%
2.9%
Q3 24
0.9%
1.9%
Q2 24
0.7%
Q1 24
1.0%
Cash Conversion
GENI
GENI
KRO
KRO
Q4 25
Q3 25
Q2 25
Q1 25
-5.66×
Q4 24
Q3 24
0.39×
Q2 24
1.96×
Q1 24
-5.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons